Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns

The diagnosis of major depressive disorder (MDD) in U.S. youth is increasing as is the rate of antidepressant medication (ADM) treatment for the disorder. Fluoxetine and escitalopram are FDA approved for the short term and maintenance treatment of MDD in youth. Placebo-controlled short-term ADM tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Safer, Daniel J., Zito, Julie Magno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797591/
https://www.ncbi.nlm.nih.gov/pubmed/31681028
http://dx.doi.org/10.3389/fpsyt.2019.00705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797591/
https://www.ncbi.nlm.nih.gov/pubmed/31681028
http://dx.doi.org/10.3389/fpsyt.2019.00705

Ejemplares similares